- Home
- USAC vs RARE Comparison
USAC vs RARE Comparison
Compare USAC & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAC
- RARE
- Stock Information
- Founded
- USAC 1998
- RARE 2010
- Country
- USAC United States
- RARE United States
- Employees
- USAC N/A
- RARE N/A
- Industry
- USAC Natural Gas Distribution
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- USAC Utilities
- RARE Health Care
- Exchange
- USAC Nasdaq
- RARE Nasdaq
- Market Cap
- USAC 3.0B
- RARE 2.6B
- IPO Year
- USAC N/A
- RARE 2014
- Fundamental
- Price
- USAC $24.51
- RARE $28.71
- Analyst Decision
- USAC Hold
- RARE Strong Buy
- Analyst Count
- USAC 4
- RARE 14
- Target Price
- USAC $25.50
- RARE $86.64
- AVG Volume (30 Days)
- USAC 208.9K
- RARE 1.4M
- Earning Date
- USAC 11-04-2025
- RARE 11-04-2025
- Dividend Yield
- USAC 8.57%
- RARE N/A
- EPS Growth
- USAC 24.37
- RARE N/A
- EPS
- USAC 0.66
- RARE N/A
- Revenue
- USAC $981,219,000.00
- RARE $610,159,000.00
- Revenue This Year
- USAC $7.21
- RARE $19.72
- Revenue Next Year
- USAC $4.61
- RARE $23.29
- P/E Ratio
- USAC $36.89
- RARE N/A
- Revenue Growth
- USAC 8.22
- RARE 26.77
- 52 Week Low
- USAC $21.24
- RARE $25.81
- 52 Week High
- USAC $30.10
- RARE $59.90
- Technical
- Relative Strength Index (RSI)
- USAC 58.95
- RARE 39.94
- Support Level
- USAC $23.91
- RARE $28.96
- Resistance Level
- USAC $24.52
- RARE $31.80
- Average True Range (ATR)
- USAC 0.56
- RARE 1.00
- MACD
- USAC 0.10
- RARE -0.24
- Stochastic Oscillator
- USAC 90.12
- RARE 2.27
About USAC USA Compression Partners LP Common Units Representing Limited Partner Interests
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.